Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Dorchy

Showing results (151-160 of 161) with videos related to

Pageof 17
Sort By:
Diabetologia|March 30, 2006
Sex- and season-dependent differences in C-peptide levels at diagnosis of immune-mediated type 1 diabetesI Weets, I Truyen, I Verschraegen, et al.
Diabetes Care|October 7, 1997
Associations of GAD65- and IA-2- autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings. The Belgian Diabetes RegistryC L Vandewalle, A Falorni, A Lernmark, et al.
Diabetes Care|August 11, 2000
Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes RegistryK Decochez, B Keymeulen, G Somers, et al.
Diabetologia|February 24, 2001
Male-to-female excess in diabetes diagnosed in early adulthood is not specific for the immune-mediated form nor is it HLA-DQ restricted: possible relation to increased body mass indexI Weets, J Van Autreve, B J Van der Auwera, et al.
European Journal of Pediatrics|August 10, 2012
Care delivery and outcomes among Belgian children and adolescents with type 1 diabetesK Doggen, N Debacker, D Beckers, et al.
Clinical and Experimental Immunology|December 4, 2012
Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patientsF K Gorus, E V Balti, I Vermeulen, et al.
Diabetes Care|July 27, 2001
Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidøre Study GroupT Danne, H B Mortensen, P Hougaard, et al.
Diabetes Care|October 27, 2001
Good metabolic control is associated with better quality of life in 2,101 adolescents with type 1 diabetesH Hoey, H J Aanstoot, F Chiarelli, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 16, 1998
Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Hvidøre Study Group on Childhood DiabetesH B Mortensen, K J Robertson, H J Aanstoot, et al.
Pediatric Diabetes|November 10, 2009
Target setting in intensive insulin management is associated with metabolic control: the Hvidoere childhood diabetes study group centre differences study 2005P G F Swift, T C Skinner, C E de Beaufort, et al.
Pageof 17

Showing results (151-160 of 161) with videos related to

Sort By:
Pageof 17
Diabetologia|March 30, 2006
Sex- and season-dependent differences in C-peptide levels at diagnosis of immune-mediated type 1 diabetesI Weets, I Truyen, I Verschraegen, et al.
Diabetes Care|October 7, 1997
Associations of GAD65- and IA-2- autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings. The Belgian Diabetes RegistryC L Vandewalle, A Falorni, A Lernmark, et al.
Diabetes Care|August 11, 2000
Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes RegistryK Decochez, B Keymeulen, G Somers, et al.
Diabetologia|February 24, 2001
Male-to-female excess in diabetes diagnosed in early adulthood is not specific for the immune-mediated form nor is it HLA-DQ restricted: possible relation to increased body mass indexI Weets, J Van Autreve, B J Van der Auwera, et al.
European Journal of Pediatrics|August 10, 2012
Care delivery and outcomes among Belgian children and adolescents with type 1 diabetesK Doggen, N Debacker, D Beckers, et al.
Clinical and Experimental Immunology|December 4, 2012
Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patientsF K Gorus, E V Balti, I Vermeulen, et al.
Diabetes Care|July 27, 2001
Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidøre Study GroupT Danne, H B Mortensen, P Hougaard, et al.
Diabetes Care|October 27, 2001
Good metabolic control is associated with better quality of life in 2,101 adolescents with type 1 diabetesH Hoey, H J Aanstoot, F Chiarelli, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 16, 1998
Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Hvidøre Study Group on Childhood DiabetesH B Mortensen, K J Robertson, H J Aanstoot, et al.
Pediatric Diabetes|November 10, 2009
Target setting in intensive insulin management is associated with metabolic control: the Hvidoere childhood diabetes study group centre differences study 2005P G F Swift, T C Skinner, C E de Beaufort, et al.
Pageof 17